emerging markets

COVID-19 underscores need to boost pharma manufacturing in emerging markets

https://pharmaphorum.com/views-and-analysis/covid-underscores-need-to-boost-pharma-manufacturing-in-emerging-markets/

Windrose Consulting Group acquires Parioforma

https://pharmaphorum.com/partner-content/windrose-consulting-group-acquires-parioforma/

The real impact of COVID-19 on emerging markets

https://pharmaphorum.com/views-analysis-market-access/the-real-impact-of-covid-19-on-emerging-markets/

Q&A: Zulf Masters on emerging markets

https://pharmaphorum.com/views-analysis-market-access/qa-zulf-masters-on-emerging-markets/

Takeda nets $660m from product selloff to Germany’s Stada

https://pharmaphorum.com/news/takeda-nets-660m-from-product-selloff-to-germanys-stada/

Navigating emerging markets – opportunities and challenges for pharma

https://pharmaphorum.com/views-analysis-market-access/navigating-emerging-markets-opportunities-and-challenges-for-pharma/

Global Pharmaceutical Regulatory Affairs Summit

https://pharmaphorum.com/events/global-pharmaceutical-regulatory-affairs-summit/

MINT: opportunities in ‘frontier’ markets?

https://pharmaphorum.com/articles/mint-opportunities-frontier-markets/

Six factors shaping healthcare in emerging markets

https://pharmaphorum.com/views-and-analysis/healthcare-emerging-markets/

1 2

Close in 10 seconds

Pharmaphorum.com

Search